Definitive Healthcare Q2 revenue $60.8M (-5% YoY); raises FY revenue guidance bottom by $3M

Definitive Healthcare Corp.

2025-Q2 EPS reported -$1.05 revenue$119,941,000

Q2 net loss $(9.3)M vs $(306.2)M (prior year included $363.6M goodwill impairment).
Adjusted net income $9.7M, down from $14.2M in Q2 2024; adjusted EBITDA $18.7M (31% margin).
Q3 2025 revenue guidance $59-60M; FY 2025 raised to $237-240M from $234-240M.
Adjusted net income per diluted share for Q3 guided at $0.05-0.06; FY at $0.22-0.23.
Customer wins include a revenue cycle management firm and a digital health org returning after non-renewal.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.